Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. The company's focus is on capex investments funded internally or through partnership (e.g., INR10-15 crores investment in new heat exchanger manufacturing unit). No information on plans for raising capital via debt or equity. Growth and expansion appear to be driven by internal accruals and strategic partnerships, not fresh fundraising. The company is also completing acquisitions (like C2C Engineering), but the funding for these acquisitions (INR 12.25 crores for 51% of C2C) is

Any current/future capex/capital investment/strategic investment?

Upcoming new facility on 36 acres with 6 lakh sq.ft construction; INR 120-150 crores capex planned; expected completion in 14-18 months. Expansion to increase crane capacity from 60 tons to 100 tons and fabrication thickness from 60 mm to 100 mm. New dedicated unit for glass-lined shell and tube heat exchangers; capex around INR 10-15 crores; planned start Q1 next year. C2C Engineering acquisition (51% stake) completed for INR 12.25 crores, enhancing capability in process design and multidisciplinary engineering solutions. Japan collaboration to increase production capacity for critica

Future growth expectations in sales/revenue/volumes?

Expected revenue growth of approximately 20-25% year-on-year. For FY26, projected top-line around INR 930-950 crores, based on 25% growth from INR 750 crores this year. New manufacturing facilities under development will increase capacity and enable higher sales. Significant capacity expansion with a new 36-acre facility adding potential INR 2,000 crores capacity in addition to existing INR 2,000 crores. Growth driven primarily by large pharma clients continuing capex; smaller clients yet to pick up. Export growth expected to accelerate in H2 FY26 with deferred orders. Glass-lined equipment an

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects a sustained growth rate of around 20% to 25% year-on-year going forward. FY ‘27 revenue is projected around INR 930-950 crores assuming 25% growth from INR 750 crores current run rate. EBITDA margins are expected to sustain around current levels (~18.5%-18.8%) with a slight potential increase due to focus on higher-margin solutions business. PAT margin on glass-lined heat exchangers is expected to improve to 15%-18% once in-house manufacturing starts. Asset utilization for new factories initially will be low but is expected to ramp up, with FY ‘28 anticipated to sho

Current/ Expected Orderbook/ Pending Orders?

Current order book is approximately INR 750 crores to INR 800 crores. Order book timeline varies with projects ranging from 4 weeks to 8 months based on customer requirements. Glass lining contributes about 35% of the revenue and order book, rest is metal equipment. The glass lining heat exchanger orders are fully booked up to March due to limited manufacturing capacity in Japan. New manufacturing unit for heat exchangers in India expected to start from April next year, which will increase capacity and allow acceptance of new orders post-March. Export orders worth INR 45 crores were

Standard Engineering Technology LtdQ3 FY26

Standard Engineering Technology Ltd Q3 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹298P/E: 69.3Market Cap: ₹5.5K Cr

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Expected revenue growth of approximately 20-25% year-on-year.
→For FY26, projected top-line around INR 930-950 crores, based on 25% growth from INR 750 crores this year.
→New manufacturing facilities under development will increase capacity and enable higher sales.
→Significant capacity expansion with a new 36-acre facility adding potential INR 2,000 crores capacity in addition to existing INR 2,000 crores.
→Growth driven primarily by large pharma clients continuing capex; smaller clients yet to pick up.
→Export growth expected to accelerate in H2 FY26 with deferred orders.
→Glass-lined equipment and heat exchangers capacities increasing, including in-house manufacturing starting next year.
→New product launches and acquisitions (e.g., C2C Engineering) to fuel growth and diversification.
→Anticipated higher utilization and sustained growth beyond FY28.

Margin guidance

Category 3

→The company expects a sustained growth rate of around 20% to 25% year-on-year going forward.
→FY ‘27 revenue is projected around INR 930-950 crores assuming 25% growth from INR 750 crores current run rate.
→EBITDA margins are expected to sustain around current levels (~18.5%-18.8%) with a slight potential increase due to focus on higher-margin solutions business.
→PAT margin on glass-lined heat exchangers is expected to improve to 15%-18% once in-house manufacturing starts.
→Asset utilization for new factories initially will be low but is expected to ramp up, with FY ‘28 anticipated to show stronger growth due to new capacity.
→New capex of INR 120-150 crores for large 36-acre facility in pipeline to support long-term growth.
→Management confident of gradual margin and return on capital (ROC) improvements with solutions and integrated offerings.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
→The company's focus is on capex investments funded internally or through partnership (e.g., INR10-15 crores investment in new heat exchanger manufacturing unit).
→No information on plans for raising capital via debt or equity.
→Growth and expansion appear to be driven by internal accruals and strategic partnerships, not fresh fundraising.
→The company is also completing acquisitions (like C2C Engineering), but the funding for these acquisitions (INR 12.25 crores for 51% of C2C) is not indicated as coming from new fundraising.

Order book

Yes

→Current order book is approximately INR 750 crores to INR 800 crores.
→Order book timeline varies with projects ranging from 4 weeks to 8 months based on customer requirements.
→Glass lining contributes about 35% of the revenue and order book, rest is metal equipment.
→The glass lining heat exchanger orders are fully booked up to March due to limited manufacturing capacity in Japan.
→New manufacturing unit for heat exchangers in India expected to start from April next year, which will increase capacity and allow acceptance of new orders post-March.
→Export orders worth INR 45 crores were deferred from H1 to H2 FY26 and expected to be fulfilled in H2.
→The company does not publicly disclose detailed order book figures beyond this range.

Capex plans

Yes

→Upcoming new facility on 36 acres with 6 lakh sq.ft construction; INR 120-150 crores capex planned; expected completion in 14-18 months.
→Expansion to increase crane capacity from 60 tons to 100 tons and fabrication thickness from 60 mm to 100 mm.
→New dedicated unit for glass-lined shell and tube heat exchangers; capex around INR 10-15 crores; planned start Q1 next year.
→C2C Engineering acquisition (51% stake) completed for INR 12.25 crores, enhancing capability in process design and multidisciplinary engineering solutions.
→Japan collaboration to increase production capacity for critical parts of heat exchangers.
→Continued investments in automation technology to increase capacity and efficiency.
→Existing facilities expect ramp-up in capacity utilization, targeting revenue scale of INR 2,000 crores from new and existing capacity.

How does Standard Engineering Technology Ltd rank vs peers in ?

Pro feature

1Standard Engineering Technology Ltd

Rev 2Mar 3

See full sector rankings

Want more stocks like Standard Engineering Technology Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio